Access Replay KOL Call: FDA Emergency Use Authorization, featuring speakers from Emergent BioSolutions Inc. (EBS)
April 06, 2020 |Chardan KOL Call: FDA Emergency Use Authorization, featuring speakers from Emergent BioSolutions Inc. (EBS) moderated by Keay Nakae, CFA, Senior Research Analyst.
Participating Management:
Sean Kirk, Executive Vice President, Manufacturing & Technical Operations
Manish Vyas, Vice President, Regulatory Affairs
Bob Burrows, Vice President, IR
For more information about Chardan’s conference call, please email CorpAccess@chardan.com.
Thank You!
We've received your information, and we're processing your request.
Get In Touch.
All fields required